Menu

Contact Us

Radiopharmaceuticals

Short isotope half-lives, dose-scheduling dependencies, and specialized site logistics. Our RTSM technology and experts are built to hold that complexity, from first participant in to database lock.

RLT specialists working alongside our RTSM and clinical supply teams under one roof.

Solutions & Services for Radiopharmaceutical Trials

The products and expertise we bring to radiopharmaceutical and RLT trials, from dose scheduling and supply through to eCOA and study-design consultancy.

ClinPhone Pro

Our next-generation unified RTSM / IRT platform, with dedicated radioligand therapy capabilities designed to manage the operational, supply, and scheduling requirements specific to RLT studies.

Learn More

ClinPhone Pro Core

Streamlined, ready-to-deploy RTSM on the same platform and quality framework, with go-live in about four weeks. A right-fit option for early-phase radiopharmaceutical studies that need proven capability fast.

Learn More

eCOA – Clin'Form

Electronic Clinical Outcome Assessment through our Kayentis partnership, available as an integrated RTSM plus eCOA solution to capture patient-reported symptoms and quality-of-life data alongside randomization and dosing.

Learn More

Perceptive Clinical Intelligence

Supply-chain and randomization consultancy plus expert training, designed to de-risk dose-scheduling and supply decisions before and during a radiopharmaceutical study.

Learn More

eClinical Delivery Services

End-to-end RTSM design, implementation, integration, validation, deployment, and support for radiopharmaceutical protocols, delivered by an embedded team of experts.

Learn More

Randomization Consultancy

Expert design of randomization and stratification strategy for dose-escalation, dosimetry, and comparator-controlled radiopharmaceutical protocols.

Learn More

Supply Chain Consultancy

Forecasting and supply modeling to protect continuity of short half-life IMP that cannot be held in stock.

Learn More

Capabilities That Matter Most in Radiopharmaceutical Trials

The four capability areas behind every study we run, applied to the specific demands of radiopharmaceutical and RLT trials.

Complex Randomization

Blocked, stratified, and dynamic randomization for dose-escalation, dosimetry, and comparator-controlled radiopharmaceutical protocols.

Trial Supply Management

Dose-scheduling dependencies, depot-to-site logistics, and expiry management for short half-life isotopes and made-to-order doses.

Clinical Study Management

Dosing-window scheduling, site readiness across nuclear medicine facilities, participant replacement, and emergency unblinding.

Data Integrity

Audit trails, data-change reporting, and real-time dashboards designed to support inspection readiness for radiopharmaceutical submissions.

Proven at Scale

6,500+Trials delivered across therapeutic areas worldwide.
3M+Participants randomized to date.
>48%Of studies in the last five years were pivotal Phase III.
500+Regulatory approvals supported.
Case study cover and inside pages
Case Study

Right-fit RTSM: how a lean biotech team reached first-participant-in on schedule

A look at how standardized configurations and expert support shortened study start-up — and what teams running Phase II and III trials can take from it.

July 24, 2026

Bring Precision to Your Radiopharmaceutical Program

Talk with our RTSM experts about the dose-scheduling, supply, and data challenges specific to your radiopharmaceutical protocol.